Holen Sie sich die Stockscreener-App
6.29
7.83%
-0.61
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
Weekly Trades: Will Atara Biotherapeutics Inc benefit from AI trendsQuarterly Market Review & Stock Portfolio Risk Management - baoquankhu1.vn
Atara schedules FDA meeting on tabelecleucel license application - Investing.com South Africa
Atara Biotherapeutics Inc Provides Regulatory Update on Tabelecleucel - marketscreener.com
Precision Trading with Atara Biotherapeutics Inc. (ATRA) Risk Zones - Stock Traders Daily
Atara (ATRA) Schedules FDA Meeting to Address CRL for Tabelecleu - GuruFocus
Atara Plans FDA Type A Meeting on EBVALLO - TipRanks
Atara schedules FDA meeting on tabelecleucel license application By Investing.com - Investing.com Canada
Atara Biotherapeutics schedules FDA Type A meeting on EBVALLO BLA complete response - TradingView
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel - Business Wire
Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus - TechStock²
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Lisata Therapeutics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Aug Closing: Can Atara Biotherapeutics Inc sustain earnings growth2026 Fundamental Recap & Risk Controlled Daily Plans - baoquankhu1.vn
Aug Chart Watch: Is Atara Biotherapeutics Inc being accumulated by smart moneyJobs Report & Weekly Breakout Stock Alerts - baoquankhu1.vn
Why Atara Biotherapeutics Inc. stock is popular among millennials2025 Trading Recap & Verified Entry Point Signals - Naître et grandir
Aug Momentum: Is Atara Biotherapeutics Inc forming a breakout patternJuly 2025 Catalysts & Short-Term Swing Trade Alerts - baoquankhu1.vn
Profit Review: Will Atara Biotherapeutics Inc benefit from green energy policiesEarnings Recap Report & Precise Swing Trade Entry Alerts - baoquankhu1.vn
ATRA Rises On Pushing For Meeting With FDA On Rare Disease Drug Rejection - Stocktwits
Atara Biotherapeutics provides regulatory update on tabelecleucel - marketscreener.com
Atara, Pierre Fabre seek FDA meeting on EBVALLO - TipRanks
Atara Biotherapeutics (ATRA) and Partner Seek FDA Meeting for Ta - GuruFocus
Atara Biotherapeutics partner seeks Type A FDA meeting on tabelecleucel following CRL - TradingView
Atara Biotherapeutics (ATRA) requests FDA Type A meeting on EBVALLO™ - Stock Titan
Atara Biotherapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
Insider sale: ATRA (NASDAQ: ATRA) 7,788 RSU shares settled 03/01/2026 - Stock Titan
ATRA (NASDAQ) insider resale notice: 4,759 RSU shares reported - Stock Titan
Technical Reactions to ATRA Trends in Macro Strategies - Stock Traders Daily
ATRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ATRA Should I Buy - Intellectia AI
Atara Biotherapeutics (ATRA) Shares Rise Despite FDA Rejection - GuruFocus
Atara jumps amid report on FDA’s U-turn on cell therapy - Seeking Alpha
Market Overview: Can Atara Biotherapeutics Inc stock double in the next yearStock Surge & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Atara Biotherapeutics Provides a Business Update - BioSpace
Atara Biotherapeutics (ATRA) Adjusts Key Financial Agreement - GuruFocus
Atara Biotherapeutics Extends Royalty Milestone, Issues Warrant - TipRanks
Atara Biotherapeutics Defers $9 Million Milestone Payment to 2028, Issues 400,000-Share Warrant to HCR - TradingView
Atara extends $9M milestone payment deadline to 2028 - Investing.com
Atara (NASDAQ: ATRA) extends $9M HCRx payment and grants 400,000-share warrant - Stock Titan
Insider Buy: Is GLBLW showing insider buyingIndex Update & Verified Chart Pattern Signals - baoquankhu1.vn
What is the Moat Score of Atara Biotherapeutics Inc.2025 Sector Review & Technical Pattern Based Buy Signals - mfd.ru
There's No Escaping Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Muted Revenues - simplywall.st
Exit Recap: Can Atara Biotherapeutics Inc. weather a recessionQuarterly Performance Summary & Weekly Top Stock Performers List - mfd.ru
What are analysts’ price targets for Atara Biotherapeutics Inc.July 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - mfd.ru
Take Profit: Will International Tower Hill Mines Ltd outperform the market in YEARJuly 2025 Short Interest & High Yield Stock Recommendations - baoquankhu1.vn
Is Atara Biotherapeutics Inc. impacted by rising ratesJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
MSN Money - MSN
Will Atara Biotherapeutics Inc. stock recover faster than peersJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - mfd.ru
Is Atara Biotherapeutics Inc. stock ready for breakout2025 Trading Recap & Long-Term Capital Growth Strategies - mfd.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc.ATRA - PR Newswire
Can Atara Biotherapeutics Inc. stock double in the next yearTrend Reversal & Community Consensus Trade Alerts - mfd.ru
How Atara Biotherapeutics Inc. stock trades during market volatility2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
How Atara Biotherapeutics Inc. stock reacts to job market dataMarket Trend Report & Technical Pattern Based Signals - mfd.ru
Nasdaq Moves: Will Atara Biotherapeutics Inc benefit from green energy policiesLayoff News & Community Supported Trade Ideas - baoquankhu1.vn
Highs Report: What analysts say about Atara Biotherapeutics Inc stockMarket Weekly Review & AI Forecast Swing Trade Picks - baoquankhu1.vn
Fundamentals Check: Does Nuveen Churchill Direct Lending Corp have pricing powerJuly 2025 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn
Can Atara Biotherapeutics Inc stock double in the next yearMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):